Selective Serotonin Reuptake Inhibitor-Induced Sexual Dysfunction: Current Management Perspectives
Murad Atmaca Department of Psychiatry, Firat University School of Medicine, Elazig, TurkeyCorrespondence: Murad AtmacaFirat (Euphrates) Universitesi, Firat Tip Merkezi, Psikiyatri Anabilim Dali, Elazig 23119, TurkeyTel +90 424 233 3555Fax +90 424 238 7688Email matmaca_p@yahoo.comAbstract: Any type o...
Guardado en:
Autor principal: | Atmaca M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e934a7a3842b4e35962f9b9782c049a0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia
por: Novick D, et al.
Publicado: (2016) -
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Najmeh Shahini, et al.
Publicado: (2021) -
Selective serotonin reuptake inhibitors may lead to improved cataract surgery outcomes in patients with amblyopia
por: Xin KZ, et al.
Publicado: (2019) -
Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
por: Mike Briley, et al.
Publicado: (2010) -
A meta-analysis of effects of selective serotonin reuptake inhibitors on blood pressure in depression treatment: outcomes from placebo and serotonin and noradrenaline reuptake inhibitor controlled trials
por: Zhong Z, et al.
Publicado: (2017)